What does Materna Medical, Inc. do?
Materna Medical is a Mountain View-based healthcare company focused on creating innovative solutions for women’s pelvic health. Their flagship product Milli® is designed to support patients suffering from vaginismus and related painful conditions, while their investigational device Ellora® aims to reduce pelvic floor muscle injury during vaginal delivery.
How much did they raise?
The company raised $20M in a Series B2 financing round led by InnovaHealth Partners, with participating investors including Wavemaker Three-Sixty Health, Kimera Limited, Women’s Venture Capital Fund, Golden Seeds, GLIN Impact Capital, Wealthing VC Club, and Citrine Angels.
What are their plans for the money?
Materna Medical plans to use the funds to further develop and expand their innovative product portfolio and advance clinical research, potentially enhancing access to effective women’s pelvic health solutions.
What have they achieved so far?
The Milli® device launched in 2019 as a wellness trainer and received FDA clearance in 2023 for over-the-counter sales, with its outcomes supported by the POMPOM study. Additionally, Ellora® is currently being evaluated in a large, randomized controlled trial in top US hospitals.